Abstract

The MinION sequencer is increasingly being used for the detection and outbreak surveillance of pathogens due to its rapid throughput. For RNA viruses, MinION’s new direct RNA sequencing is the next significant development. Direct RNA sequencing studies are currently limited and comparisons of its diagnostic performance relative to different DNA sequencing approaches are lacking as a result. We sought to address this gap and sequenced six subtypes from the mycovirus CHV-1 using MinION’s direct RNA sequencing and DNA sequencing based on a targeted viral amplicon. Reads from both techniques could correctly identify viral presence and species using BLAST, though direct RNA reads were more frequently misassigned to closely related CHV species. De novo consensus sequences were error prone but suitable for viral species identification. However, subtype identification was less accurate from both reads and consensus sequences. This is due to the high sequencing error rate and the limited sequence divergence between some CHV-1 subtypes. Importantly, neither RNA nor amplicon sequencing reads could be used to obtain reliable intra-host variants. Overall, both sequencing techniques were suitable for virus detection, though limitations are present due to the error rate of MinION reads.

Highlights

  • The MinION (Oxford Nanopore Technologies Ltd., Oxford, UK, hereafter ONT) has shown it has the potential to revolutionize diagnostic protocols and pathogen surveillance

  • (95% modal accuracy for MinION R9 reported by ONT in 2020) and this likely prevents its use in routine diagnostics

  • Consensus sequences have been used for pathogen identification in diagnostic studies and we explored if they offered greater accuracy than read-based methods

Read more

Summary

Introduction

The MinION (Oxford Nanopore Technologies Ltd., Oxford, UK, hereafter ONT) has shown it has the potential to revolutionize diagnostic protocols and pathogen surveillance. This is thanks to the device’s portability, low cost, and short sequencing time relative to other high-throughput sequencers [1]. Utilized in high-profile human disease outbreaks (e.g., Ebola, [2,3]; Salmonella, [4]), the MinION was shown to support rapid in situ pathogen detection and disease surveillance. In a clear example of the device’s full potential for routine diagnostics, harmful DNA viruses of Cassava were confirmed within a crop in less than three hours by MinION sequencing. The error rate present in MinION reads remains significantly higher than other high-throughput sequencers (95% modal accuracy for MinION R9 reported by ONT in 2020) and this likely prevents its use in routine diagnostics

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call